TSTaylor L. Simonian

Taylor L. Simonian

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Taylor L. Simonian has a total of 23 co-authors. Here are the top co-authors by number of shared publications:

  • Andrew P. McMahon

    Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California, USA

    3 shared publications
  • Jinjin Guo

    Department of Stem Cell Biology and Regenerative Medicine, Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, Keck School of Medicine of the University of Southern California, Los Angeles, California

    3 shared publications
  • Amanda S. Meyer

    Department of Stem Cell Biology and Regenerative Medicine, Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, Keck School of Medicine University of Southern California Los Angeles California USA

    1 shared publication
  • Antonio Vidal-Puig

    MRC Institute of Metabolic Science, Metabolic Research Laboratories, University of Cambridge, Cambridge, UK

    1 shared publication
  • Fatima Baldo

    Milner Therapeutics Institute, University of Cambridge, Cambridge, CB2 0AW, United Kingdom

    1 shared publication
  • Hannah M. L. Bazin

    Milner Therapeutics Institute, University of Cambridge, Cambridge, CB2 0AW, United Kingdom

    1 shared publication

Latest Publications

  • Open Access

    An amyloid-β/APP regulatory layer in human brown adipocyte recruitment identifies repurposable drugs for thermogenic fat expansion

    by Hannah M. L. Bazin, Sonia Rodríguez-Fdez, Fatima Baldo, Iman D. Mali, Nazuk Gupta, Milidili Maimaiti, Taylor L. Simonian, Mark Campbell, Possawee Prasertsuk, Namshik Han, et al.

    Brown adipose tissue (BAT) increases energy expenditure but is scarce in adults, yet most strategies focus on activating existing thermogenic adipocytes rather than recruiting new ones. We integrate human single-nucleus transcriptomics with protein-interaction and knowledge-graph analyses to identify stage-specific, druggable programmes governing brown adipogenesis. This pipeline resolved four ordered transcriptional states and three transitions, revealing an amyloid-β/APP regulatory layer and nominating APP as a central signalling hub. Most prioritised compounds altered differentiation or metabolic phenotype, several substantially. Phenserine (APP-lowering) and sacubitril (neprilysin inhibitor) promoted differentiation through distinct mechanisms and stages and could be combined sequentially for benefit. Phenserine increased differentiation across three human models and, in mice, expanded BAT mass and increased thermogenic capacity. Together, these findings reveal targetable control points in human brown adipocyte recruitment, nominate repurposable drugs for BAT expansion, and establish a generalisable framework coupling single-cell transcriptomics with network-based drug repurposing across staged biological systems.

  • Enhanced Expression of the Female-Biased Gene Gsta2 in Male Proximal Tubule Cells Improves Renal Resilience to Ischemia-Reperfusion Injury

    by Shun-Yang Cheng, Jinjin Guo, Taylor L. Simonian, Paolo Caldarelli, Andrew P. McMahon

    Key Points: Elevated Gsta2 expression in female proximal tubules associates with female resilience to ischemia-reperfusion injury. Transgenic expression of Gsta2 in male proximal tubule cells directed by human HNF4A enhancers ameliorated ischemia-reperfusion injury outcomes. Ectopic Gsta2 attenuated protein peroxidation and double-strand DNA breakage, reduced fibrosis, and improved proximal tubule repair. Background: Genetic sex is an important determinant of kidney injury and repair, with female kidneys typically exhibiting greater resilience to AKI. Among the sexually dimorphic genes in mouse proximal tubule cells, Gsta2 , encoding an NFE2 like BZIP transcription factor 2–regulated antioxidant enzyme, is strongly enriched in females. Here, we hypothesized that augmenting Gsta2 expression in male proximal tubule cells will enhance resistance to ischemia-reperfusion injury (IRI). Methods: To enable proximal tubule cell–specific expression of transgenes, we mapped and verified enhancer regions directing proximal tubule expression of human HNF4A. A synthetic HNF4A enhancer cassette driving Gsta2 was introduced into a safe harbor locus in transgenic mice, thereby enhancing the expression of Gsta2 in male mice. After unilateral nephrectomy, transgenic and wild-type male mice were subjected to IRI. Post-IRI outcomes were assessed by examining kidney function, histologic injury, and fibrotic progression for up to 28 days postinjury. Results: Enhancing Gsta2 expression in male proximal tubule cells led to significantly higher glomerular filtration rates and attenuated fibrotic remodeling after IRI. Early-phase transcriptional analyses 4 hours postinjury showed reduced expression of immediate early genes ( Jun , Fos , Egr1 ), suggesting a reduced stress response, diminished DNA double-strand DNA breaks (gamma-H2AX, the phosphorylated form of the histone variant H2AX incorporation into chromatin), and lower protein peroxidation. Later-stage transgenic kidneys exhibited a reduction in fibrosis-associated transcripts ( Acta2 , Col1a1 , Col3a1 ) and markers of failed proximal tubule cells repair ( Havcr1 , Vcam1 , Ccl2 ). Conclusions: Ectopic expression of Gsta2 in male proximal tubule cells reduced oxidative injury, injury-associated fibrosis, and maladaptive stress signaling after IRI.


  • Open Access

    Nfkb1 Removal from Proximal Tubule Cells Improves Renal Tubular Outcomes Following Ischemia Reperfusion Injury

    by Shun-Yang Cheng, Kari Koppitch, Jinjin Guo, Nathan Moy, Taylor L. Simonian, Parker C. Wilson, Andrew P. McMahon

    Key Points: Persistent NF-κB signaling associates within injured proximal tubule cells (PTCs) that fail to repair on kidney injury. Removing activity of Nfkb1, a transcriptional effector of NF-κB signaling, in PTCs enhances PTC repair and decreases injury associated fibrosis. Coexpression of Nfkb1 and Relb in injured PTCs suggests additional improvement from comprehensive targeting of NF-κB transcriptional regulators. Background: CKD is a significant global health burden. AKI is a risk factor of progression to CKD. Recent studies have linked failure in proximal tubule repair as a potential contributing factor to CKD in mouse and human studies. Failed repair proximal tubule cells (FR-PTCs), initially presenting at the site of maximal sensitivity to ischemia reperfusion injury and spreading to more cortical regions over time, adopt a senescence-associated secretory phenotype linked to activation of the NF-kB pathway. Several transcriptional regulatory factors mediate NF-kB pathway action. Of these, Nfkb1 is prominent within FR-PTCs and chromatin studies predict Nfkb1 interactions with pathology-associated gene targets. Methods: To examine the role of NF-kB in nephron injury outcomes, we removed Nfkb1 activity within the nephron lineage of the mouse kidney and examined the kidney's response to bilateral ischemia reperfusion injury. Results: Single-cell transcriptional analysis showed a significant reduction of inflammation-associated gene expression, including Ccl2, Birc3, Spp1, Cd47, and Traf1, in Nfkb1-deficient FR-PTCs. A reduced pathological signature correlated with normalized expression of genes associated with healthy proximal tubule function, including Cubn, Kap, and a number of solute carriers. Single-nucleus Assay for Transposase-Accessible Chromatin seq analysis linked transcriptomic changes to enhancer regulation, particularly marked opening of chromatin for targets of hepatocyte nuclear factor family members associated with normal regulation of gene expression in proximal tubule cells. Conclusions: Examining Assay for Transposase-Accessible Chromatin seq motif predictions and performing direct immunolabeling studies suggested Relb, another transcriptional mediator of NF-κB transcriptional responses with overlapping targeting specificity to Nfkb1, may partially compensate for the loss of Nfkb1. These studies support future efforts to remove ongoing NF-κB signaling within nephrons as a potential therapeutic strategy to target the AKI-to-CKD transition.


  • Open Access

    Sex and Depot Specific Adipocyte Proteome Profiling In Vivo via Intracellular Proximity Labeling

    by Taylor L. Simonian, Amanda S. Meyer, Jinjin Guo, Jihui Sha, James A. Wohlschlegel, Ilia A. Droujinine, Norbert Perrimon, Andrew P. McMahon

    Adipose tissue has varying distributions and metabolic properties between the sexes. Inherent sex‐specific differences in adipocytes may heighten the risk of metabolic disease in males. Analysis of the adipocyte proteome can potentially provide important insight. To enable cell‐type specific proteomic profiling in vivo, we genetically engineered a mouse line for cell‐type specific production of a promiscuous biotin ligase (BirA*G3) facilitating the rapid isolation of biotinylated cell‐type specific proteomes. Adipocyte‐specific activation of cytoplasmic BirA*G3 led to robust biotinylation of adipocyte proteins across all major fat depots. Comparison of brown adipose tissue (BAT) and subcutaneous white adipose tissue (SAT) proteomes identified 229 brown adipose‐enriched and 35 white adipose‐enriched proteins. Regional comparison of white fat depots revealed additional differences across depots. Comparison of male and female depots identified sexually dimorphic adipose proteins: AHNAK predominating in the male and ACOT2 in the female. These findings validate the genetic model and highlight insights to be gained through targeted profiling of adipocytes. The genetic tool adds to existing approaches for in vivo proximity profiling of cell‐type specific proteome programs.